| Phase I study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR-T, in patients with advanced hepatocellular carcinoma (HCC). Q Zhang, Q Fu, W Cao, H Wang, X Xu, J Huang, A Zou, J Zhu, H Wan, ... Journal of Clinical Oncology 42 (16_suppl), 4019-4019, 2024 | | 2024 |
| Clinical outcomes from a phase I clinical trial of a novel oncolytic virus VG161 in patients with hepatocellular carcinoma (HCC) refractory after 2 prior lines of therapy … Y Shen, X Liang, X Jin, Q Tan, R Zhao, G Wei, T Fang, Y Li, L Wang, ... Journal of Clinical Oncology 42 (16_suppl), 4105-4105, 2024 | | 2024 |
| Efficacy and safety of envafolimab plus lenvatinib combined with TACE in initially unresectable hepatocellular carcinoma: An open-label, single-arm, phase II study. X Bai, Y Chen, J Zhang, W Hu, X Li, Y Shen, M Zhang, J Wu, S Gao, J Yu, ... Journal of Clinical Oncology 42 (16_suppl), 4108-4108, 2024 | | 2024 |
| Adjuvant therapy with donafenib plus anti–PD-1 antibody for patients (pts) with hepatocellular carcinoma (HCC) at high risk of recurrence after resection (PATH study). Y Chen, Y Shen, M Zhang, J Wu, S Gao, R Que, J Yu, X Tang, X Bai, ... Journal of Clinical Oncology 42 (16_suppl), e16228-e16228, 2024 | | 2024 |
| First-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with other solid tumors: Safety and efficacy results from a phase I study. X Bai, Q Xu, X Liang, Q Chu, X Zhang, Y Chen, N Xu, W Fang, J Shan, ... Journal of Clinical Oncology 42 (16_suppl), e14593-e14593, 2024 | | 2024 |
| Universal antifungal prophylaxis effectively prevents fungal bloodstream infection in pediatric liver transplant recipients: a retrospective real-world study W Wang, Y Wang, Y Zhang, W Zhang, X Bai, Q Zhang, T Liang International Journal of Infectious Diseases 143, 107003, 2024 | | 2024 |
| The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity … K Huang, T Qian, W Chen, M Lao, H Li, WC Lin, BW Chen, X Bai, S Gao, ... BMC cancer 24 (1), 620, 2024 | | 2024 |
| Inhibition of DEF‐p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer S Huang, J Yang, T Xie, Y Jiang, Y Hong, X Liu, X He, D Buratto, D Zhang, ... Advanced Science, 2401845, 2024 | | 2024 |
| TFPI from erythroblasts drives heme production in central macrophages promoting erythropoiesis in polycythemia JK Ma, LD Su, LL Feng, JL Li, L Pan, Q Danzeng, Y Li, T Shang, XL Zhan, ... Nature Communications 15 (1), 3976, 2024 | | 2024 |
| Energy sensor AMPK gamma regulates translation via phosphatase PPP6C independent of AMPK alpha Q Zhou, B Hao, X Cao, L Gao, Z Yu, Y Zhao, M Zhu, G Zhong, F Chi, X Dai, ... Molecular Cell 84 (9), 1816, 2024 | | 2024 |
| Health research in the era of artificial intelligence: Advances in gene-editing study M Dai, X Li, Q Zhang, T Liang, X Huang, Q Fu Medicine Plus, 100027, 2024 | | 2024 |
| Improve the prediction of liver transplant mortality based on pre-transplant factors: A multi-center study from China: Mortality prediction of LT P Jin, W Zhang, L Sun, H Lv, X Duan, Y Zhang, X Bai, Z Zhu, J Fung, ... Digestive and Liver Disease 56 (5), 818-826, 2024 | | 2024 |
| Risk factors for post-operative portal vein stenosis in pediatric liver transplantation: a single center case-control study Y Qian, W Zhang, W Wang, Z Li, Y Shao, S Gao, J Wu, J Yu, M Zhang, ... Pediatric Surgery International 40 (1), 113, 2024 | | 2024 |
| IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signaling C Zheng, J Wang, Y Zhou, Y Duan, R Zheng, Y Xie, X Wei, J Wu, H Shen, ... Cell Reports 43 (4), 2024 | 1 | 2024 |
| Nuclear KRT19 is a transcriptional co-repressor promoting histone deacetylation and liver tumorigenesis S Han, H Fan, G Zhong, L Ni, W Shi, Y Fang, C Wang, L Wang, L Song, ... Hepatology, 10.1097, 2024 | | 2024 |
| Clinical characteristics and outcomes of liver transplant recipients infected by Omicron during the opening up of the dynamic zero-coronavirus disease policy in China: A … W Zhang, R Wang, P Jin, X Yu, W Wang, Y Zhang, X Bai, T Liang American Journal of Transplantation 24 (4), 631-640, 2024 | | 2024 |
| Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study Y Wang, X Sun, C Chen, H Ge, J Sun, E Li, Z Cai, Q Fu, X Sun, J Wu, ... Cancer Letters 585, 216654, 2024 | | 2024 |
| Fructose-1, 6-bisphosphatase 1 dephosphorylates and inhibits TERT for tumor suppression M Li, Z Wang, J Tao, H Jiang, H Yang, D Guo, H Zhao, X He, S Luo, ... Nature chemical biology, 1-9, 2024 | | 2024 |
| Cell of Origin of Pancreatic cancer: Novel Findings and Current Understanding C Zheng, J Wang, J Wang, Q Zhang, T Liang Pancreas 53 (3), e288-e297, 2024 | | 2024 |
| Single-cell RNA sequencing highlights epithelial and microenvironmental heterogeneity in malignant progression of pancreatic ductal adenocarcinoma J Li, T Wei, K Ma, J Zhang, J Lu, J Zhao, J Huang, T Zeng, Y Xie, Y Liang, ... Cancer Letters 584, 216607, 2024 | | 2024 |
Qihan Fu 傅琦涵Second Affiliated Hospital, Zhejiang University School of Medicine在 zju.edu.cn 的电子邮件经过验证
